Health

The recent approval by the FDA of the neffy epinephrine nasal spray, developed by ARS Pharmaceuticals, marks a significant milestone in emergency allergy treatment. This breakthrough product provides a non-injectable alternative for the management of type I allergic reactions, including anaphylaxis, in both adult and pediatric patients. The approval of neffy comes as a welcome
0 Comments